
    
      PROTOCOL OUTLINE:

      This is a randomized, double blind study.

      Patients are randomized to one of two treatment arms.

      Arm I: Patients receive standard dose oral valacyclovir three times a day on Days 1-7.

      Arm II: Patients receive higher dose oral valacyclovir three times a day on Days 1-7.

      Both arms: Patients begin treatment within 72 hours after onset of zoster rash.

      Quality of life is assessed on Days 1, 14, and 28 during study and then every 4 weeks through
      Week 24. Pain is assessed on Days 1-28 during study, and then weekly through Week 24. Medical
      resource utilization is assessed on Days 1, 8, 14, and 18 during study and then every 4 weeks
      through Week 24.

      Patients are followed every 4 weeks through Week 24.
    
  